SB 1983
bill banning mRNA products for communicable disease
Died in committee
Verdict: No flags
Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade
Caption
relating to the manufacture, sale, and distribution of products developed using mRNA material in the prevention or treatment of a communicable disease.
Caption from analyzed text · version I.
Summary
No making, selling or handing out mRNA products to prevent or treat disease.
The bill adds a new prohibited act to the Texas Food, Drug, and Cosmetic Act that bars anyone from making, selling, or handing out a product developed using mRNA material to prevent or treat a communicable disease. It touches drug makers, pharmacies, clinics, distributors, and anyone else in the supply chain for products such as mRNA vaccines, with mRNA material defined as a substance that introduces mRNA matching a viral protein. Starting September 1, 2025, these products could not legally be made, sold, or distributed in Texas, and the state's existing enforcement tools for prohibited acts under that chapter would apply.
Labels
Labels: QUICK READ: 128 WORDS. The bill as filed runs 128 words, counting the existing law it amends and the text it strikes. The median 89R bill as filed runs 441 words (derived, 8,702 graded bills, snapshot Oct 19, 2026).NEVER GOT A HEARING. Filed Mar 6, 2025 and referred to the Senate Health & Human Services committee. No public hearing. The bill died.
Receipt
The receipt
89R-SB1983 · 2025-03-06
SOLD BY
ITEM
relating to the manufacture, sale, and distribution of products developed using mRNA material in the prevention or treatment of a communicable disease.
WHAT IT DOES
No making, selling or handing out mRNA products to prevent or treat disease.
The bill adds a new prohibited act to the Texas Food, Drug, and Cosmetic Act that bars anyone from making, selling, or handing out a product developed using mRNA material to prevent or treat a communicable disease. It touches drug makers, pharmacies, clinics, distributors, and anyone else in the supply chain for products such as mRNA vaccines, with mRNA material defined as a substance that introduces mRNA matching a viral protein. Starting September 1, 2025, these products could not legally be made, sold, or distributed in Texas, and the state's existing enforcement tools for prohibited acts under that chapter would apply.
CHARGES
[ ] NONE FOUND
TOTAL
No fiscal note in the loaded record.
HISTORY
- Received by the Secretary of the Senate
- Filed
- Read first time
- Referred to Health & Human Services
FILED UNDER
No verified beat found.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
CAMPAIGN PAID FOR BY
Donors
Not tied to this bill.
Sources
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Jul 1, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Texans for Lawsuit Reform PAC$135,000.00
Texans for Lawsuit Reform PAC
$135,000.00
- Cash
- $129,000.00
- Paid by others
- $6,000.00
- Total
- $135,000.00
Also funds 124 other sitting lawmakers.
Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Sep 12, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100987789, 101010195, 101040645, 101069307, 101073278.
Texans United for a Conservative Majority PAC$116,000.00
Texans United for a Conservative Majority PAC
$116,000.00
- Cash
- $110,000.00
- Paid by others
- $6,000.00
- Total
- $116,000.00
Also funds 30 other sitting lawmakers.
Derived recipient stock · Sep 3, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Jun 27, 2025 to Oct 5, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101010195, 101033131, 101073278.
Bryan Hughes Campaign$100,000.00
Bryan Hughes Campaign
$100,000.00
- Cash
- $100,000.00
- Paid by others
- $0.00
- Total
- $100,000.00
Also funds 0 other sitting lawmakers.
Derived recipient stock · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.
Name match, not a verified identity: normalized filed name and state.
Sources
Derived itemized flow · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101073278.
Missing data does not establish zero giving. Display amounts are rounded.
Texans for Lawsuit Reform PAC
$135,000.00
- Cash
- $129,000.00
- Paid by others
- $6,000.00
- Total
- $135,000.00
Also funds 124 other sitting lawmakers.
Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Sep 12, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100987789, 101010195, 101040645, 101069307, 101073278.
Texans United for a Conservative Majority PAC
$116,000.00
- Cash
- $110,000.00
- Paid by others
- $6,000.00
- Total
- $116,000.00
Also funds 30 other sitting lawmakers.
Derived recipient stock · Sep 3, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Jun 27, 2025 to Oct 5, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101010195, 101033131, 101073278.
Bryan Hughes Campaign
$100,000.00
- Cash
- $100,000.00
- Paid by others
- $0.00
- Total
- $100,000.00
Also funds 0 other sitting lawmakers.
Derived recipient stock · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.
Name match, not a verified identity: normalized filed name and state.
Sources
Derived itemized flow · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101073278.
Votes
No floor vote loaded for this bill.
Fiscal
No fiscal note in the loaded record.
How this was graded
Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.
Sources
Texas Senate · Filed Mar 6, 2025
03/17/2025 S Referred to Health & Human Services
Texas Legislature Online · Introduced
Data snapshot Oct 26, 2026 at 4:20 AM CDT. Grades, charges, quotes and corrections follow the published record.
Senate committee · Health & Human Services · Final status: Died in committee
Companion
HB 3176 by Virdell (identical)
Subjects
Health--General
Health--Other Diseases & Medical Conditions
IMMUNIZATIONS
MEDICINE & PRESCRIPTION DRUGS
Text
The text as introduced · 128 words
89R13102 AB-D By: Hall S.B. No. 1983 A BILL TO BE ENTITLED AN ACT relating to the manufacture, sale, and distribution of products developed using mRNA material in the prevention or treatment of a communicable disease. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subchapter B, Chapter 431, Health and Safety Code, is amended by adding Section 431.0215 to read as follows: Sec. 431.0215. ADDITIONAL PROHIBITED ACTS. (a) In this section, "mRNA material" means a substance that introduces messenger ribonucleic acid (mRNA) corresponding to a viral protein. (b) A person may not manufacture, sell, or distribute a product developed through the use of mRNA material in the prevention or treatment of a communicable disease. SECTION 2. This Act takes effect September 1, 2025.